# Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis

> **NCT02093767** · NA · COMPLETED · sponsor: **University of Alberta** · enrollment: 24 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DIETARY_SUPPLEMENT:** Synergy1

## Key facts

- **NCT ID:** NCT02093767
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-09
- **Final completion:** 2011-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02093767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02093767, "Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02093767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*